nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethadione—CYP3A4—Thiotepa—urinary bladder cancer	0.105	0.206	CbGbCtD
Trimethadione—CYP2E1—Etoposide—urinary bladder cancer	0.0938	0.184	CbGbCtD
Trimethadione—CYP2C8—Fluorouracil—urinary bladder cancer	0.084	0.165	CbGbCtD
Trimethadione—CYP2C8—Etoposide—urinary bladder cancer	0.0701	0.138	CbGbCtD
Trimethadione—CYP2C9—Fluorouracil—urinary bladder cancer	0.0586	0.115	CbGbCtD
Trimethadione—CYP2C9—Cisplatin—urinary bladder cancer	0.0498	0.0978	CbGbCtD
Trimethadione—CYP3A4—Etoposide—urinary bladder cancer	0.0284	0.0559	CbGbCtD
Trimethadione—CYP3A4—Doxorubicin—urinary bladder cancer	0.0194	0.0381	CbGbCtD
Trimethadione—CYP2C19—urine—urinary bladder cancer	0.00559	0.192	CbGeAlD
Trimethadione—CYP2C9—urine—urinary bladder cancer	0.00434	0.149	CbGeAlD
Trimethadione—CYP2E1—urine—urinary bladder cancer	0.00411	0.141	CbGeAlD
Trimethadione—CYP3A4—urine—urinary bladder cancer	0.00331	0.113	CbGeAlD
Trimethadione—Gingival bleeding—Doxorubicin—urinary bladder cancer	0.00195	0.00657	CcSEcCtD
Trimethadione—Vomiting—Valrubicin—urinary bladder cancer	0.00195	0.00655	CcSEcCtD
Trimethadione—Rash—Valrubicin—urinary bladder cancer	0.00193	0.0065	CcSEcCtD
Trimethadione—Dermatitis—Valrubicin—urinary bladder cancer	0.00193	0.00649	CcSEcCtD
Trimethadione—Headache—Valrubicin—urinary bladder cancer	0.00192	0.00645	CcSEcCtD
Trimethadione—Somnolence—Mitomycin—urinary bladder cancer	0.00187	0.00631	CcSEcCtD
Trimethadione—Decreased appetite—Mitomycin—urinary bladder cancer	0.00183	0.00617	CcSEcCtD
Trimethadione—Nausea—Valrubicin—urinary bladder cancer	0.00182	0.00612	CcSEcCtD
Trimethadione—Fatigue—Mitomycin—urinary bladder cancer	0.00182	0.00612	CcSEcCtD
Trimethadione—Pancytopenia—Thiotepa—urinary bladder cancer	0.00177	0.00596	CcSEcCtD
Trimethadione—Feeling abnormal—Mitomycin—urinary bladder cancer	0.00174	0.00585	CcSEcCtD
Trimethadione—Irritability—Fluorouracil—urinary bladder cancer	0.0017	0.00573	CcSEcCtD
Trimethadione—Vaginal haemorrhage—Epirubicin—urinary bladder cancer	0.00162	0.00544	CcSEcCtD
Trimethadione—Irritability—Cisplatin—urinary bladder cancer	0.00161	0.00543	CcSEcCtD
Trimethadione—Albuminuria—Epirubicin—urinary bladder cancer	0.0016	0.0054	CcSEcCtD
Trimethadione—Epistaxis—Thiotepa—urinary bladder cancer	0.00157	0.00528	CcSEcCtD
Trimethadione—Agranulocytosis—Thiotepa—urinary bladder cancer	0.00155	0.00522	CcSEcCtD
Trimethadione—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00153	0.00514	CcSEcCtD
Trimethadione—Asthenia—Mitomycin—urinary bladder cancer	0.00151	0.00509	CcSEcCtD
Trimethadione—Haemoglobin—Thiotepa—urinary bladder cancer	0.0015	0.00505	CcSEcCtD
Trimethadione—Vaginal haemorrhage—Doxorubicin—urinary bladder cancer	0.0015	0.00504	CcSEcCtD
Trimethadione—Haemorrhage—Thiotepa—urinary bladder cancer	0.00149	0.00502	CcSEcCtD
Trimethadione—Pancytopenia—Gemcitabine—urinary bladder cancer	0.00149	0.00501	CcSEcCtD
Trimethadione—Albuminuria—Doxorubicin—urinary bladder cancer	0.00148	0.00499	CcSEcCtD
Trimethadione—CYP2E1—prostate gland—urinary bladder cancer	0.00147	0.0505	CbGeAlD
Trimethadione—Neutropenia—Gemcitabine—urinary bladder cancer	0.00147	0.00494	CcSEcCtD
Trimethadione—Pancytopenia—Fluorouracil—urinary bladder cancer	0.00146	0.00493	CcSEcCtD
Trimethadione—Pancytopenia—Cisplatin—urinary bladder cancer	0.00139	0.00467	CcSEcCtD
Trimethadione—Vomiting—Mitomycin—urinary bladder cancer	0.00134	0.00451	CcSEcCtD
Trimethadione—Rash—Mitomycin—urinary bladder cancer	0.00133	0.00447	CcSEcCtD
Trimethadione—Dermatitis—Mitomycin—urinary bladder cancer	0.00133	0.00447	CcSEcCtD
Trimethadione—Headache—Mitomycin—urinary bladder cancer	0.00132	0.00445	CcSEcCtD
Trimethadione—Alopecia—Thiotepa—urinary bladder cancer	0.00132	0.00444	CcSEcCtD
Trimethadione—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00131	0.00439	CcSEcCtD
Trimethadione—Epistaxis—Fluorouracil—urinary bladder cancer	0.0013	0.00437	CcSEcCtD
Trimethadione—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00128	0.00432	CcSEcCtD
Trimethadione—Pancytopenia—Etoposide—urinary bladder cancer	0.00127	0.00428	CcSEcCtD
Trimethadione—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00126	0.00425	CcSEcCtD
Trimethadione—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00126	0.00423	CcSEcCtD
Trimethadione—Neutropenia—Etoposide—urinary bladder cancer	0.00125	0.00422	CcSEcCtD
Trimethadione—Nausea—Mitomycin—urinary bladder cancer	0.00125	0.00422	CcSEcCtD
Trimethadione—CYP2E1—seminal vesicle—urinary bladder cancer	0.00125	0.0427	CbGeAlD
Trimethadione—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00124	0.00418	CcSEcCtD
Trimethadione—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00123	0.00416	CcSEcCtD
Trimethadione—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.0012	0.00404	CcSEcCtD
Trimethadione—Hiccups—Epirubicin—urinary bladder cancer	0.0012	0.00403	CcSEcCtD
Trimethadione—CYP2C8—renal system—urinary bladder cancer	0.00119	0.0409	CbGeAlD
Trimethadione—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.00119	0.004	CcSEcCtD
Trimethadione—Leukopenia—Thiotepa—urinary bladder cancer	0.00116	0.00391	CcSEcCtD
Trimethadione—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00112	0.00378	CcSEcCtD
Trimethadione—Agranulocytosis—Etoposide—urinary bladder cancer	0.00111	0.00375	CcSEcCtD
Trimethadione—Alopecia—Gemcitabine—urinary bladder cancer	0.00111	0.00373	CcSEcCtD
Trimethadione—Hiccups—Doxorubicin—urinary bladder cancer	0.00111	0.00373	CcSEcCtD
Trimethadione—Alopecia—Fluorouracil—urinary bladder cancer	0.00109	0.00367	CcSEcCtD
Trimethadione—Lymphadenopathy—Methotrexate—urinary bladder cancer	0.00109	0.00366	CcSEcCtD
Trimethadione—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00104	0.0035	CcSEcCtD
Trimethadione—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00104	0.00349	CcSEcCtD
Trimethadione—Alopecia—Cisplatin—urinary bladder cancer	0.00103	0.00348	CcSEcCtD
Trimethadione—Lymphadenopathy—Epirubicin—urinary bladder cancer	0.00102	0.00343	CcSEcCtD
Trimethadione—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.00101	0.00341	CcSEcCtD
Trimethadione—Erythema multiforme—Etoposide—urinary bladder cancer	0.00101	0.00341	CcSEcCtD
Trimethadione—Anorexia—Thiotepa—urinary bladder cancer	0.00101	0.0034	CcSEcCtD
Trimethadione—CYP2E1—renal system—urinary bladder cancer	0.00101	0.0344	CbGeAlD
Trimethadione—CYP2C19—vagina—urinary bladder cancer	0.000991	0.034	CbGeAlD
Trimethadione—CYP2E1—urethra—urinary bladder cancer	0.000987	0.0338	CbGeAlD
Trimethadione—Malaise—Gemcitabine—urinary bladder cancer	0.000986	0.00332	CcSEcCtD
Trimethadione—Dermatitis exfoliative—Methotrexate—urinary bladder cancer	0.000984	0.00331	CcSEcCtD
Trimethadione—Leukopenia—Gemcitabine—urinary bladder cancer	0.000979	0.00329	CcSEcCtD
Trimethadione—Leukopenia—Fluorouracil—urinary bladder cancer	0.000962	0.00324	CcSEcCtD
Trimethadione—CYP2C8—female reproductive system—urinary bladder cancer	0.000956	0.0328	CbGeAlD
Trimethadione—Paraesthesia—Thiotepa—urinary bladder cancer	0.000952	0.0032	CcSEcCtD
Trimethadione—Alopecia—Etoposide—urinary bladder cancer	0.000948	0.00319	CcSEcCtD
Trimethadione—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.000945	0.00318	CcSEcCtD
Trimethadione—Somnolence—Thiotepa—urinary bladder cancer	0.000943	0.00317	CcSEcCtD
Trimethadione—Lymphadenopathy—Doxorubicin—urinary bladder cancer	0.000942	0.00317	CcSEcCtD
Trimethadione—Decreased appetite—Thiotepa—urinary bladder cancer	0.000922	0.0031	CcSEcCtD
Trimethadione—Dermatitis exfoliative—Epirubicin—urinary bladder cancer	0.000921	0.0031	CcSEcCtD
Trimethadione—Discomfort—Gemcitabine—urinary bladder cancer	0.00092	0.00309	CcSEcCtD
Trimethadione—Malaise—Cisplatin—urinary bladder cancer	0.000919	0.00309	CcSEcCtD
Trimethadione—Fatigue—Thiotepa—urinary bladder cancer	0.000914	0.00308	CcSEcCtD
Trimethadione—Leukopenia—Cisplatin—urinary bladder cancer	0.000912	0.00307	CcSEcCtD
Trimethadione—Discomfort—Fluorouracil—urinary bladder cancer	0.000904	0.00304	CcSEcCtD
Trimethadione—Irritability—Methotrexate—urinary bladder cancer	0.000886	0.00298	CcSEcCtD
Trimethadione—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000874	0.00294	CcSEcCtD
Trimethadione—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000874	0.00294	CcSEcCtD
Trimethadione—Diplopia—Epirubicin—urinary bladder cancer	0.000869	0.00292	CcSEcCtD
Trimethadione—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000867	0.00292	CcSEcCtD
Trimethadione—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000866	0.00291	CcSEcCtD
Trimethadione—CYP2C8—vagina—urinary bladder cancer	0.000865	0.0296	CbGeAlD
Trimethadione—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000859	0.00289	CcSEcCtD
Trimethadione—Discomfort—Cisplatin—urinary bladder cancer	0.000857	0.00288	CcSEcCtD
Trimethadione—Dermatitis exfoliative—Doxorubicin—urinary bladder cancer	0.000852	0.00287	CcSEcCtD
Trimethadione—Anorexia—Gemcitabine—urinary bladder cancer	0.00085	0.00286	CcSEcCtD
Trimethadione—CYP2C9—female reproductive system—urinary bladder cancer	0.00085	0.0291	CbGeAlD
Trimethadione—Malaise—Etoposide—urinary bladder cancer	0.000842	0.00283	CcSEcCtD
Trimethadione—Vertigo—Etoposide—urinary bladder cancer	0.000839	0.00282	CcSEcCtD
Trimethadione—Abdominal pain—Thiotepa—urinary bladder cancer	0.000838	0.00282	CcSEcCtD
Trimethadione—Anorexia—Fluorouracil—urinary bladder cancer	0.000836	0.00281	CcSEcCtD
Trimethadione—Leukopenia—Etoposide—urinary bladder cancer	0.000836	0.00281	CcSEcCtD
Trimethadione—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.000814	0.00274	CcSEcCtD
Trimethadione—CYP3A4—renal system—urinary bladder cancer	0.000809	0.0277	CbGeAlD
Trimethadione—Insomnia—Gemcitabine—urinary bladder cancer	0.000807	0.00272	CcSEcCtD
Trimethadione—CYP2E1—female reproductive system—urinary bladder cancer	0.000805	0.0276	CbGeAlD
Trimethadione—Diplopia—Doxorubicin—urinary bladder cancer	0.000804	0.00271	CcSEcCtD
Trimethadione—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000801	0.0027	CcSEcCtD
Trimethadione—Eosinophilia—Methotrexate—urinary bladder cancer	0.000795	0.00267	CcSEcCtD
Trimethadione—Insomnia—Fluorouracil—urinary bladder cancer	0.000793	0.00267	CcSEcCtD
Trimethadione—Somnolence—Gemcitabine—urinary bladder cancer	0.000793	0.00267	CcSEcCtD
Trimethadione—Anorexia—Cisplatin—urinary bladder cancer	0.000793	0.00267	CcSEcCtD
Trimethadione—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000788	0.00265	CcSEcCtD
Trimethadione—Discomfort—Etoposide—urinary bladder cancer	0.000785	0.00264	CcSEcCtD
Trimethadione—Somnolence—Fluorouracil—urinary bladder cancer	0.00078	0.00262	CcSEcCtD
Trimethadione—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000776	0.00261	CcSEcCtD
Trimethadione—Fatigue—Gemcitabine—urinary bladder cancer	0.000769	0.00259	CcSEcCtD
Trimethadione—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000763	0.00257	CcSEcCtD
Trimethadione—Pancytopenia—Methotrexate—urinary bladder cancer	0.000762	0.00256	CcSEcCtD
Trimethadione—Asthenia—Thiotepa—urinary bladder cancer	0.000761	0.00256	CcSEcCtD
Trimethadione—Neutropenia—Methotrexate—urinary bladder cancer	0.00075	0.00253	CcSEcCtD
Trimethadione—Pruritus—Thiotepa—urinary bladder cancer	0.00075	0.00253	CcSEcCtD
Trimethadione—Paraesthesia—Cisplatin—urinary bladder cancer	0.000747	0.00251	CcSEcCtD
Trimethadione—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000746	0.00251	CcSEcCtD
Trimethadione—Eosinophilia—Epirubicin—urinary bladder cancer	0.000744	0.0025	CcSEcCtD
Trimethadione—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000735	0.00247	CcSEcCtD
Trimethadione—Anorexia—Etoposide—urinary bladder cancer	0.000726	0.00244	CcSEcCtD
Trimethadione—Decreased appetite—Cisplatin—urinary bladder cancer	0.000723	0.00243	CcSEcCtD
Trimethadione—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000723	0.00243	CcSEcCtD
Trimethadione—Drowsiness—Methotrexate—urinary bladder cancer	0.000716	0.00241	CcSEcCtD
Trimethadione—Pancytopenia—Epirubicin—urinary bladder cancer	0.000713	0.0024	CcSEcCtD
Trimethadione—Neutropenia—Epirubicin—urinary bladder cancer	0.000702	0.00236	CcSEcCtD
Trimethadione—Eosinophilia—Doxorubicin—urinary bladder cancer	0.000688	0.00232	CcSEcCtD
Trimethadione—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000685	0.00231	CcSEcCtD
Trimethadione—Paraesthesia—Etoposide—urinary bladder cancer	0.000684	0.0023	CcSEcCtD
Trimethadione—Weight decreased—Epirubicin—urinary bladder cancer	0.000679	0.00229	CcSEcCtD
Trimethadione—Somnolence—Etoposide—urinary bladder cancer	0.000677	0.00228	CcSEcCtD
Trimethadione—Epistaxis—Methotrexate—urinary bladder cancer	0.000675	0.00227	CcSEcCtD
Trimethadione—Vomiting—Thiotepa—urinary bladder cancer	0.000674	0.00227	CcSEcCtD
Trimethadione—Drowsiness—Epirubicin—urinary bladder cancer	0.00067	0.00225	CcSEcCtD
Trimethadione—Rash—Thiotepa—urinary bladder cancer	0.000669	0.00225	CcSEcCtD
Trimethadione—Dermatitis—Thiotepa—urinary bladder cancer	0.000668	0.00225	CcSEcCtD
Trimethadione—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000668	0.00225	CcSEcCtD
Trimethadione—Headache—Thiotepa—urinary bladder cancer	0.000664	0.00224	CcSEcCtD
Trimethadione—Decreased appetite—Etoposide—urinary bladder cancer	0.000662	0.00223	CcSEcCtD
Trimethadione—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00066	0.00222	CcSEcCtD
Trimethadione—Fatigue—Etoposide—urinary bladder cancer	0.000657	0.00221	CcSEcCtD
Trimethadione—Neutropenia—Doxorubicin—urinary bladder cancer	0.00065	0.00219	CcSEcCtD
Trimethadione—CYP3A4—female reproductive system—urinary bladder cancer	0.000648	0.0222	CbGeAlD
Trimethadione—Haemoglobin—Methotrexate—urinary bladder cancer	0.000646	0.00217	CcSEcCtD
Trimethadione—Haemorrhage—Methotrexate—urinary bladder cancer	0.000642	0.00216	CcSEcCtD
Trimethadione—Hepatitis—Methotrexate—urinary bladder cancer	0.000642	0.00216	CcSEcCtD
Trimethadione—Asthenia—Gemcitabine—urinary bladder cancer	0.00064	0.00215	CcSEcCtD
Trimethadione—Epistaxis—Epirubicin—urinary bladder cancer	0.000632	0.00213	CcSEcCtD
Trimethadione—Pruritus—Gemcitabine—urinary bladder cancer	0.000631	0.00212	CcSEcCtD
Trimethadione—Nausea—Thiotepa—urinary bladder cancer	0.00063	0.00212	CcSEcCtD
Trimethadione—Weight decreased—Doxorubicin—urinary bladder cancer	0.000629	0.00212	CcSEcCtD
Trimethadione—Feeling abnormal—Etoposide—urinary bladder cancer	0.000628	0.00211	CcSEcCtD
Trimethadione—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000625	0.0021	CcSEcCtD
Trimethadione—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000623	0.0021	CcSEcCtD
Trimethadione—Pruritus—Fluorouracil—urinary bladder cancer	0.000621	0.00209	CcSEcCtD
Trimethadione—Drowsiness—Doxorubicin—urinary bladder cancer	0.00062	0.00208	CcSEcCtD
Trimethadione—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000607	0.00204	CcSEcCtD
Trimethadione—Haemoglobin—Epirubicin—urinary bladder cancer	0.000604	0.00203	CcSEcCtD
Trimethadione—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000604	0.00367	CbGpPWpGaD
Trimethadione—Abdominal pain—Etoposide—urinary bladder cancer	0.000602	0.00203	CcSEcCtD
Trimethadione—Hepatitis—Epirubicin—urinary bladder cancer	0.000601	0.00202	CcSEcCtD
Trimethadione—Haemorrhage—Epirubicin—urinary bladder cancer	0.000601	0.00202	CcSEcCtD
Trimethadione—CYP2C8—Biological oxidations—CYP4B1—urinary bladder cancer	0.0006	0.00364	CbGpPWpGaD
Trimethadione—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000598	0.00363	CbGpPWpGaD
Trimethadione—Asthenia—Cisplatin—urinary bladder cancer	0.000597	0.00201	CcSEcCtD
Trimethadione—CYP2C19—Biological oxidations—UGT2B7—urinary bladder cancer	0.000595	0.00361	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—NAT1—urinary bladder cancer	0.000593	0.0036	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—GSTO2—urinary bladder cancer	0.000593	0.0036	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000592	0.00359	CbGpPWpGaD
Trimethadione—CACNA1G—NCAM signaling for neurite out-growth—HRAS—urinary bladder cancer	0.000592	0.00359	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000587	0.00356	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000585	0.00355	CbGpPWpGaD
Trimethadione—Epistaxis—Doxorubicin—urinary bladder cancer	0.000584	0.00197	CcSEcCtD
Trimethadione—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000578	0.00195	CcSEcCtD
Trimethadione—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000568	0.00191	CcSEcCtD
Trimethadione—Alopecia—Methotrexate—urinary bladder cancer	0.000568	0.00191	CcSEcCtD
Trimethadione—Vomiting—Gemcitabine—urinary bladder cancer	0.000567	0.00191	CcSEcCtD
Trimethadione—Rash—Gemcitabine—urinary bladder cancer	0.000563	0.00189	CcSEcCtD
Trimethadione—Dermatitis—Gemcitabine—urinary bladder cancer	0.000562	0.00189	CcSEcCtD
Trimethadione—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000559	0.00188	CcSEcCtD
Trimethadione—Headache—Gemcitabine—urinary bladder cancer	0.000559	0.00188	CcSEcCtD
Trimethadione—Vomiting—Fluorouracil—urinary bladder cancer	0.000558	0.00188	CcSEcCtD
Trimethadione—Hepatitis—Doxorubicin—urinary bladder cancer	0.000556	0.00187	CcSEcCtD
Trimethadione—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000556	0.00187	CcSEcCtD
Trimethadione—Rash—Fluorouracil—urinary bladder cancer	0.000553	0.00186	CcSEcCtD
Trimethadione—Dermatitis—Fluorouracil—urinary bladder cancer	0.000553	0.00186	CcSEcCtD
Trimethadione—Headache—Fluorouracil—urinary bladder cancer	0.00055	0.00185	CcSEcCtD
Trimethadione—Asthenia—Etoposide—urinary bladder cancer	0.000547	0.00184	CcSEcCtD
Trimethadione—CYP2C9—Biological oxidations—UGT2B7—urinary bladder cancer	0.000542	0.00329	CbGpPWpGaD
Trimethadione—Pruritus—Etoposide—urinary bladder cancer	0.000539	0.00181	CcSEcCtD
Trimethadione—CYP2C19—Biological oxidations—CYP4B1—urinary bladder cancer	0.000536	0.00325	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000535	0.00325	CbGpPWpGaD
Trimethadione—Alopecia—Epirubicin—urinary bladder cancer	0.000531	0.00179	CcSEcCtD
Trimethadione—Nausea—Gemcitabine—urinary bladder cancer	0.00053	0.00178	CcSEcCtD
Trimethadione—Vomiting—Cisplatin—urinary bladder cancer	0.000529	0.00178	CcSEcCtD
Trimethadione—CYP2C19—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000528	0.00321	CbGpPWpGaD
Trimethadione—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000526	0.00177	CcSEcCtD
Trimethadione—Rash—Cisplatin—urinary bladder cancer	0.000524	0.00176	CcSEcCtD
Trimethadione—Dermatitis—Cisplatin—urinary bladder cancer	0.000524	0.00176	CcSEcCtD
Trimethadione—Nausea—Fluorouracil—urinary bladder cancer	0.000521	0.00175	CcSEcCtD
Trimethadione—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000519	0.00175	CcSEcCtD
Trimethadione—CYP2C8—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000507	0.00308	CbGpPWpGaD
Trimethadione—Malaise—Methotrexate—urinary bladder cancer	0.000504	0.0017	CcSEcCtD
Trimethadione—Vertigo—Methotrexate—urinary bladder cancer	0.000502	0.00169	CcSEcCtD
Trimethadione—Leukopenia—Methotrexate—urinary bladder cancer	0.000501	0.00168	CcSEcCtD
Trimethadione—Nausea—Cisplatin—urinary bladder cancer	0.000494	0.00166	CcSEcCtD
Trimethadione—Alopecia—Doxorubicin—urinary bladder cancer	0.000491	0.00165	CcSEcCtD
Trimethadione—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	0.000488	0.00296	CbGpPWpGaD
Trimethadione—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000486	0.00163	CcSEcCtD
Trimethadione—Vomiting—Etoposide—urinary bladder cancer	0.000484	0.00163	CcSEcCtD
Trimethadione—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000482	0.00292	CbGpPWpGaD
Trimethadione—Rash—Etoposide—urinary bladder cancer	0.00048	0.00162	CcSEcCtD
Trimethadione—Dermatitis—Etoposide—urinary bladder cancer	0.00048	0.00161	CcSEcCtD
Trimethadione—Headache—Etoposide—urinary bladder cancer	0.000477	0.00161	CcSEcCtD
Trimethadione—Malaise—Epirubicin—urinary bladder cancer	0.000472	0.00159	CcSEcCtD
Trimethadione—Discomfort—Methotrexate—urinary bladder cancer	0.00047	0.00158	CcSEcCtD
Trimethadione—Vertigo—Epirubicin—urinary bladder cancer	0.00047	0.00158	CcSEcCtD
Trimethadione—Leukopenia—Epirubicin—urinary bladder cancer	0.000468	0.00158	CcSEcCtD
Trimethadione—CYP2E1—Biological oxidations—NAT2—urinary bladder cancer	0.000462	0.0028	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000456	0.00276	CbGpPWpGaD
Trimethadione—CYP2C19—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000453	0.00275	CbGpPWpGaD
Trimethadione—Nausea—Etoposide—urinary bladder cancer	0.000453	0.00152	CcSEcCtD
Trimethadione—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000449	0.00151	CcSEcCtD
Trimethadione—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000447	0.0015	CcSEcCtD
Trimethadione—Discomfort—Epirubicin—urinary bladder cancer	0.00044	0.00148	CcSEcCtD
Trimethadione—Malaise—Doxorubicin—urinary bladder cancer	0.000437	0.00147	CcSEcCtD
Trimethadione—Vertigo—Doxorubicin—urinary bladder cancer	0.000435	0.00146	CcSEcCtD
Trimethadione—Anorexia—Methotrexate—urinary bladder cancer	0.000435	0.00146	CcSEcCtD
Trimethadione—Leukopenia—Doxorubicin—urinary bladder cancer	0.000433	0.00146	CcSEcCtD
Trimethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000421	0.00255	CbGpPWpGaD
Trimethadione—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000418	0.00141	CcSEcCtD
Trimethadione—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000413	0.00251	CbGpPWpGaD
Trimethadione—Insomnia—Methotrexate—urinary bladder cancer	0.000413	0.00139	CcSEcCtD
Trimethadione—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000413	0.0025	CbGpPWpGaD
Trimethadione—Paraesthesia—Methotrexate—urinary bladder cancer	0.00041	0.00138	CcSEcCtD
Trimethadione—Discomfort—Doxorubicin—urinary bladder cancer	0.000407	0.00137	CcSEcCtD
Trimethadione—Anorexia—Epirubicin—urinary bladder cancer	0.000407	0.00137	CcSEcCtD
Trimethadione—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000407	0.00247	CbGpPWpGaD
Trimethadione—Somnolence—Methotrexate—urinary bladder cancer	0.000406	0.00137	CcSEcCtD
Trimethadione—CYP2C8—Biological oxidations—NAT2—urinary bladder cancer	0.000399	0.00242	CbGpPWpGaD
Trimethadione—Decreased appetite—Methotrexate—urinary bladder cancer	0.000397	0.00133	CcSEcCtD
Trimethadione—CYP2C8—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000394	0.00239	CbGpPWpGaD
Trimethadione—Fatigue—Methotrexate—urinary bladder cancer	0.000393	0.00132	CcSEcCtD
Trimethadione—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000391	0.00237	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000391	0.00237	CbGpPWpGaD
Trimethadione—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000387	0.0013	CcSEcCtD
Trimethadione—Insomnia—Epirubicin—urinary bladder cancer	0.000386	0.0013	CcSEcCtD
Trimethadione—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000386	0.00234	CbGpPWpGaD
Trimethadione—Paraesthesia—Epirubicin—urinary bladder cancer	0.000383	0.00129	CcSEcCtD
Trimethadione—Somnolence—Epirubicin—urinary bladder cancer	0.00038	0.00128	CcSEcCtD
Trimethadione—CACNA1G—Developmental Biology—NCOR1—urinary bladder cancer	0.000377	0.00229	CbGpPWpGaD
Trimethadione—Anorexia—Doxorubicin—urinary bladder cancer	0.000377	0.00127	CcSEcCtD
Trimethadione—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000376	0.00127	CcSEcCtD
Trimethadione—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000373	0.00126	CcSEcCtD
Trimethadione—Decreased appetite—Epirubicin—urinary bladder cancer	0.000371	0.00125	CcSEcCtD
Trimethadione—CYP2E1—Biological oxidations—HPGDS—urinary bladder cancer	0.000369	0.00224	CbGpPWpGaD
Trimethadione—Fatigue—Epirubicin—urinary bladder cancer	0.000368	0.00124	CcSEcCtD
Trimethadione—Abdominal pain—Methotrexate—urinary bladder cancer	0.000361	0.00121	CcSEcCtD
Trimethadione—CYP2E1—Biological oxidations—GSTT1—urinary bladder cancer	0.000358	0.00217	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000358	0.00217	CbGpPWpGaD
Trimethadione—Insomnia—Doxorubicin—urinary bladder cancer	0.000357	0.0012	CcSEcCtD
Trimethadione—CYP2C19—Biological oxidations—NAT2—urinary bladder cancer	0.000356	0.00216	CbGpPWpGaD
Trimethadione—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000355	0.00119	CcSEcCtD
Trimethadione—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000353	0.00214	CbGpPWpGaD
Trimethadione—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000352	0.00118	CcSEcCtD
Trimethadione—CYP2C19—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000352	0.00213	CbGpPWpGaD
Trimethadione—Somnolence—Doxorubicin—urinary bladder cancer	0.000351	0.00118	CcSEcCtD
Trimethadione—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000349	0.00118	CcSEcCtD
Trimethadione—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000344	0.00116	CcSEcCtD
Trimethadione—Fatigue—Doxorubicin—urinary bladder cancer	0.000341	0.00115	CcSEcCtD
Trimethadione—Abdominal pain—Epirubicin—urinary bladder cancer	0.000338	0.00114	CcSEcCtD
Trimethadione—CACNA1G—Axon guidance—RHOA—urinary bladder cancer	0.000329	0.002	CbGpPWpGaD
Trimethadione—Asthenia—Methotrexate—urinary bladder cancer	0.000327	0.0011	CcSEcCtD
Trimethadione—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000326	0.0011	CcSEcCtD
Trimethadione—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000325	0.00197	CbGpPWpGaD
Trimethadione—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000323	0.00109	CcSEcCtD
Trimethadione—Pruritus—Methotrexate—urinary bladder cancer	0.000323	0.00109	CcSEcCtD
Trimethadione—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000322	0.00195	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000321	0.00194	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—HPGDS—urinary bladder cancer	0.000319	0.00194	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000318	0.00193	CbGpPWpGaD
Trimethadione—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000312	0.00105	CcSEcCtD
Trimethadione—CYP2C8—Biological oxidations—GSTT1—urinary bladder cancer	0.00031	0.00188	CbGpPWpGaD
Trimethadione—Asthenia—Epirubicin—urinary bladder cancer	0.000306	0.00103	CcSEcCtD
Trimethadione—CACNA1G—Axon guidance—ERBB2—urinary bladder cancer	0.000305	0.00185	CbGpPWpGaD
Trimethadione—Pruritus—Epirubicin—urinary bladder cancer	0.000302	0.00102	CcSEcCtD
Trimethadione—CYP2C8—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000299	0.00181	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—CDK4—urinary bladder cancer	0.000298	0.00181	CbGpPWpGaD
Trimethadione—Vomiting—Methotrexate—urinary bladder cancer	0.00029	0.000976	CcSEcCtD
Trimethadione—Rash—Methotrexate—urinary bladder cancer	0.000288	0.000968	CcSEcCtD
Trimethadione—Dermatitis—Methotrexate—urinary bladder cancer	0.000287	0.000967	CcSEcCtD
Trimethadione—Headache—Methotrexate—urinary bladder cancer	0.000286	0.000962	CcSEcCtD
Trimethadione—CYP2C19—Biological oxidations—HPGDS—urinary bladder cancer	0.000285	0.00173	CbGpPWpGaD
Trimethadione—Asthenia—Doxorubicin—urinary bladder cancer	0.000284	0.000954	CcSEcCtD
Trimethadione—Pruritus—Doxorubicin—urinary bladder cancer	0.00028	0.000941	CcSEcCtD
Trimethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000277	0.00168	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—GSTT1—urinary bladder cancer	0.000276	0.00168	CbGpPWpGaD
Trimethadione—Vomiting—Epirubicin—urinary bladder cancer	0.000272	0.000914	CcSEcCtD
Trimethadione—Nausea—Methotrexate—urinary bladder cancer	0.000271	0.000912	CcSEcCtD
Trimethadione—CACNA1G—Developmental Biology—PPARG—urinary bladder cancer	0.00027	0.00164	CbGpPWpGaD
Trimethadione—Rash—Epirubicin—urinary bladder cancer	0.000269	0.000906	CcSEcCtD
Trimethadione—Dermatitis—Epirubicin—urinary bladder cancer	0.000269	0.000905	CcSEcCtD
Trimethadione—Headache—Epirubicin—urinary bladder cancer	0.000268	0.0009	CcSEcCtD
Trimethadione—CYP2C19—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000267	0.00162	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—MMP9—urinary bladder cancer	0.000261	0.00159	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.00026	0.00158	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—CREBBP—urinary bladder cancer	0.00026	0.00158	CbGpPWpGaD
Trimethadione—Nausea—Epirubicin—urinary bladder cancer	0.000254	0.000854	CcSEcCtD
Trimethadione—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000252	0.00153	CbGpPWpGaD
Trimethadione—Vomiting—Doxorubicin—urinary bladder cancer	0.000251	0.000845	CcSEcCtD
Trimethadione—Rash—Doxorubicin—urinary bladder cancer	0.000249	0.000838	CcSEcCtD
Trimethadione—Dermatitis—Doxorubicin—urinary bladder cancer	0.000249	0.000838	CcSEcCtD
Trimethadione—CYP2E1—Biological oxidations—GSTP1—urinary bladder cancer	0.000248	0.00151	CbGpPWpGaD
Trimethadione—Headache—Doxorubicin—urinary bladder cancer	0.000248	0.000833	CcSEcCtD
Trimethadione—CYP2E1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000245	0.00149	CbGpPWpGaD
Trimethadione—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000243	0.00148	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—SRC—urinary bladder cancer	0.000241	0.00146	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—RHOA—urinary bladder cancer	0.000235	0.00143	CbGpPWpGaD
Trimethadione—Nausea—Doxorubicin—urinary bladder cancer	0.000235	0.00079	CcSEcCtD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00023	0.0014	CbGpPWpGaD
Trimethadione—CYP2E1—Biological oxidations—GSTM1—urinary bladder cancer	0.000228	0.00138	CbGpPWpGaD
Trimethadione—CYP2E1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000225	0.00137	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—ERBB2—urinary bladder cancer	0.000218	0.00132	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—GSTP1—urinary bladder cancer	0.000215	0.0013	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000214	0.0013	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000212	0.00128	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000211	0.00128	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—EGFR—urinary bladder cancer	0.000211	0.00128	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000206	0.00125	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—KRAS—urinary bladder cancer	0.0002	0.00121	CbGpPWpGaD
Trimethadione—CYP2C8—Biological oxidations—GSTM1—urinary bladder cancer	0.000197	0.0012	CbGpPWpGaD
Trimethadione—CYP2C8—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000195	0.00118	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000192	0.00116	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000189	0.00115	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000188	0.00114	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—MMP9—urinary bladder cancer	0.000187	0.00113	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—EP300—urinary bladder cancer	0.000177	0.00107	CbGpPWpGaD
Trimethadione—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.000176	0.00107	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000175	0.00106	CbGpPWpGaD
Trimethadione—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000174	0.00105	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000172	0.00105	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—SRC—urinary bladder cancer	0.000172	0.00104	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000171	0.00104	CbGpPWpGaD
Trimethadione—CACNA1G—Axon guidance—HRAS—urinary bladder cancer	0.00017	0.00103	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000166	0.00101	CbGpPWpGaD
Trimethadione—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.000161	0.000974	CbGpPWpGaD
Trimethadione—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000158	0.000961	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	0.000152	0.000923	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—EGFR—urinary bladder cancer	0.000151	0.000915	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—NAT1—urinary bladder cancer	0.000144	0.000875	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	0.000144	0.000875	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—TNF—urinary bladder cancer	0.000144	0.000871	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—KRAS—urinary bladder cancer	0.000142	0.000864	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	0.000132	0.0008	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	0.000131	0.000798	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	0.000125	0.000756	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—NAT1—urinary bladder cancer	0.000125	0.000756	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000123	0.000744	CbGpPWpGaD
Trimethadione—CACNA1G—Developmental Biology—HRAS—urinary bladder cancer	0.000121	0.000735	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	0.000119	0.000721	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	0.000117	0.000712	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000115	0.000699	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	0.000114	0.000692	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000114	0.000689	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	0.000112	0.00068	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	0.000111	0.000675	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—NAT1—urinary bladder cancer	0.000111	0.000675	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000109	0.000664	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	0.000109	0.000663	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	0.000107	0.000649	CbGpPWpGaD
Trimethadione—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	0.000106	0.000642	CbGpPWpGaD
Trimethadione—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000104	0.000634	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	0.000103	0.000623	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	0.000102	0.000617	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	0.000101	0.000616	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—NAT1—urinary bladder cancer	0.000101	0.000616	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.98e-05	0.000605	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	9.69e-05	0.000588	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	9.45e-05	0.000573	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	9.28e-05	0.000563	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	9.16e-05	0.000556	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—TYMP—urinary bladder cancer	8.74e-05	0.00053	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	8.65e-05	0.000525	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	8.43e-05	0.000512	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	8.35e-05	0.000507	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—NAT2—urinary bladder cancer	7.9e-05	0.000479	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	7.89e-05	0.000479	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	7.69e-05	0.000466	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.57e-05	0.00046	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—TYMP—urinary bladder cancer	7.55e-05	0.000458	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	7.25e-05	0.00044	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	7.06e-05	0.000428	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—NAT2—urinary bladder cancer	6.83e-05	0.000414	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—RRM2—urinary bladder cancer	6.82e-05	0.000414	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.76e-05	0.00041	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—TYMP—urinary bladder cancer	6.74e-05	0.000409	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.69e-05	0.000406	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.69e-05	0.000406	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.47e-05	0.000393	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	6.32e-05	0.000383	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ENO2—urinary bladder cancer	6.32e-05	0.000383	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.16e-05	0.000374	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—TYMP—urinary bladder cancer	6.15e-05	0.000373	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	6.13e-05	0.000372	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	6.12e-05	0.000371	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—NAT2—urinary bladder cancer	6.1e-05	0.00037	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.9e-05	0.000358	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—RRM2—urinary bladder cancer	5.89e-05	0.000358	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—NAT2—urinary bladder cancer	5.56e-05	0.000337	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.51e-05	0.000334	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ENO2—urinary bladder cancer	5.46e-05	0.000331	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	5.46e-05	0.000331	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.43e-05	0.000329	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	5.29e-05	0.000321	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—RRM2—urinary bladder cancer	5.26e-05	0.000319	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.21e-05	0.000316	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5.2e-05	0.000316	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—NQO1—urinary bladder cancer	5.09e-05	0.000309	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	5.07e-05	0.000308	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	4.87e-05	0.000296	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ENO2—urinary bladder cancer	4.87e-05	0.000296	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.84e-05	0.000294	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—RRM2—urinary bladder cancer	4.8e-05	0.000291	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	4.73e-05	0.000287	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.65e-05	0.000282	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	4.44e-05	0.00027	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ENO2—urinary bladder cancer	4.44e-05	0.00027	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.42e-05	0.000268	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—NQO1—urinary bladder cancer	4.4e-05	0.000267	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	4.31e-05	0.000262	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.27e-05	0.000259	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	4.25e-05	0.000258	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.24e-05	0.000257	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—TYMP—urinary bladder cancer	4.05e-05	0.000246	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—TYMS—urinary bladder cancer	3.95e-05	0.00024	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—NQO1—urinary bladder cancer	3.93e-05	0.000238	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	3.9e-05	0.000237	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	3.9e-05	0.000237	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.81e-05	0.000231	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—GPX1—urinary bladder cancer	3.74e-05	0.000227	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.72e-05	0.000226	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	3.67e-05	0.000223	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	3.67e-05	0.000223	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.67e-05	0.000222	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—NQO1—urinary bladder cancer	3.58e-05	0.000217	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.55e-05	0.000215	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.47e-05	0.000211	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	3.45e-05	0.000209	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—TYMS—urinary bladder cancer	3.41e-05	0.000207	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	3.37e-05	0.000205	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	3.37e-05	0.000205	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.32e-05	0.000202	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	3.28e-05	0.000199	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—GPX1—urinary bladder cancer	3.23e-05	0.000196	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	3.17e-05	0.000192	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.17e-05	0.000192	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.16e-05	0.000192	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—TYMS—urinary bladder cancer	3.05e-05	0.000185	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.03e-05	0.000184	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	3.01e-05	0.000183	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	3.01e-05	0.000183	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.99e-05	0.000181	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.98e-05	0.000181	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.93e-05	0.000178	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.93e-05	0.000178	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.89e-05	0.000175	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.88e-05	0.000175	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.84e-05	0.000172	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.83e-05	0.000172	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2.8e-05	0.00017	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.78e-05	0.000169	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.74e-05	0.000167	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.74e-05	0.000167	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	2.69e-05	0.000163	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.66e-05	0.000161	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—GPX1—urinary bladder cancer	2.63e-05	0.00016	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	2.58e-05	0.000157	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	2.43e-05	0.000147	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PPARG—urinary bladder cancer	2.42e-05	0.000147	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.36e-05	0.000143	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	2.32e-05	0.000141	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	2.2e-05	0.000133	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.16e-05	0.000131	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	2.07e-05	0.000126	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.97e-05	0.00012	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.97e-05	0.000119	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.92e-05	0.000116	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.9e-05	0.000115	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.89e-05	0.000115	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.83e-05	0.000111	CbGpPWpGaD
Trimethadione—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.83e-05	0.000111	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.81e-05	0.00011	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.81e-05	0.00011	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.73e-05	0.000105	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.7e-05	0.000103	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.7e-05	0.000103	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.66e-05	0.000101	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.6e-05	9.71e-05	CbGpPWpGaD
Trimethadione—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.58e-05	9.6e-05	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.55e-05	9.39e-05	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.48e-05	8.98e-05	CbGpPWpGaD
Trimethadione—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.41e-05	8.57e-05	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.35e-05	8.19e-05	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.3e-05	7.87e-05	CbGpPWpGaD
Trimethadione—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.29e-05	7.81e-05	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.25e-05	7.56e-05	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	1.02e-05	6.19e-05	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.9e-06	5.4e-05	CbGpPWpGaD
Trimethadione—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.49e-06	5.15e-05	CbGpPWpGaD
